BMO Capital Markets Raises Clorox (NYSE:CLX) Price Target to $165.00

Clorox (NYSE:CLX) had its price objective upped by BMO Capital Markets from $153.00 to $165.00 in a report published on Friday, November 2nd. They currently have a buy rating on the stock.

A number of other equities research analysts also recently commented on the stock. Barclays set a $138.00 price objective on shares of Clorox and gave the company a hold rating in a research report on Thursday, November 1st. Deutsche Bank upped their target price on shares of Clorox from $123.00 to $124.00 and gave the company a sell rating in a report on Thursday, November 1st. Wells Fargo & Co restated a hold rating on shares of Clorox in a report on Wednesday, October 31st. Zacks Investment Research cut shares of Clorox from a buy rating to a hold rating in a report on Friday, October 5th. Finally, Argus upgraded shares of Clorox from a hold rating to a buy rating and set a $175.00 target price for the company in a report on Tuesday, September 25th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus price target of $141.64.

CLX traded up $1.03 during trading hours on Friday, hitting $158.77. 1,225,605 shares of the company’s stock were exchanged, compared to its average volume of 1,253,548. Clorox has a 12-month low of $113.57 and a 12-month high of $159.17. The company has a market cap of $20.25 billion, a P/E ratio of 25.36, a PEG ratio of 3.89 and a beta of 0.28. The company has a quick ratio of 0.65, a current ratio of 1.07 and a debt-to-equity ratio of 3.38.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 EPS for the quarter, beating the Zacks’ consensus estimate of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same period in the prior year, the firm posted $1.46 EPS. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. Research analysts forecast that Clorox will post 6.31 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be paid a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date of this dividend is Tuesday, October 30th. Clorox’s dividend payout ratio is currently 61.34%.

In other Clorox news, COO Dawn C. Willoughby sold 3,387 shares of the company’s stock in a transaction on Wednesday, September 5th. The shares were sold at an average price of $148.01, for a total transaction of $501,309.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Diego J. Barral sold 12,880 shares of the company’s stock in a transaction on Tuesday, November 6th. The stock was sold at an average price of $157.98, for a total transaction of $2,034,782.40. Following the transaction, the senior vice president now owns 18,603 shares of the company’s stock, valued at approximately $2,938,901.94. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 96,353 shares of company stock valued at $14,762,793. 1.40% of the stock is owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Cornerstone Wealth Management LLC purchased a new position in shares of Clorox in the 2nd quarter valued at about $105,000. Fort L.P. purchased a new position in Clorox during the 2nd quarter valued at about $129,000. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new position in Clorox during the 3rd quarter valued at about $130,000. Whittier Trust Co. of Nevada Inc. increased its holdings in Clorox by 1,297.4% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock valued at $148,000 after acquiring an additional 1,505 shares in the last quarter. Finally, Legacy Advisors LLC purchased a new position in Clorox during the 3rd quarter valued at about $150,000. Institutional investors and hedge funds own 78.35% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Why do companies engage in swaps?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply